Latest Breaking News On - Allison soss - Page 3 : comparemela.com

SELLAS Life Sciences (SLS) Announces Update on Phase 3 REGAL Clinical Trial of Galinpepimut-S

SELLAS Life Sciences (SLS) Announces Update on Phase 3 REGAL Clinical Trial of Galinpepimut-S
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Raquel cona michaela fawcettAngelos stergiouDragan cicicAllison sossBaylor university medical centerSteering committeeDrug administrationData monitoring committeeGenfleet therapeutics shanghai incStrategic communicationsLife sciences group incClinical developmentMemorial sloan kettering cancer centerHematologic malignancies researchSciences groupIndependent data monitoring committee

SELLAS Life Sciences Provides Business Update and Reports Third Quarter 2022 Financial Results

14.11.2022 - – Cash Position of $21.3 Million as of September 30, 2022 – – Hosting Phase 3 REGAL Study Update Webcast Today at 8:30 a.m. ET – NEW YORK, Nov. 14, 2022 (GLOBE NEWSWIRE) - SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or .

United statesHong kongRaquel cona michaela fawcettAngelos stergiouDragan cicicKatherine bach kalinAllison sossBaylor university medical centerSteering committeeGenfleet therapeutics shanghai incAmerican society of hematologyMerck co incStrategic communicationsLife sciences group incD medicines incClinical development

SELLAS Announces Confirmatory Top-Line Data Showing Survival and Clinical Benefits Based on the Final Analysis of the Phase 1/2 Clinical Trial of Galinpepimut-S in Combination with Keytruda® (pembrolizumab) in Patients with WT1+ Platinum-Resistant Advanced Ovarian Cancer

- Median Overall Survival for GPS Combination was 18.4 Months Compared to 13.8 months in a Checkpoint Inhibitor Single Agent Study in a Similar Patient Population Treated with Checkpoint Inhibitor. | November 10, 2022

United statesAngelos stergiouMichaela fawcettBruno bastosAllison sossRaquel conaHerbert wertheim college of medicineCompany wilmsGenfleet therapeutics shanghai incMerck co incStrategic communicationsLife sciences group incMerck sharp dohmeMiami cancer instituteMemorial sloan kettering cancer centerGlobenewswire inc

Treasure Global Signs MOU With Leading Regional Payment Gateway Provider in South-East Asia, iPay88

Treasure Global Signs MOU With Leading Regional Payment Gateway Provider in South-East Asia, iPay88
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Kuala lumpurSam teoSouth east asiaAllison sossStrategic communicationsService solutionTreasure global incHolding sdn bhdSecurities exchangePartnership supports regional expansion strategyPayment gateway partner forProprietary appSdn bhdSouth east asianManage softwareChief executive officer

Treasure Global Signs MOU With Leading Regional Payment

iPay88 To Become TGI’s Exclusive Payment Gateway Partner For its Proprietary App, ZCITYPartnership Supports Regional Expansion Strategy For ZCITY and Tazte.

Kuala lumpurSam teoSouth east asiaAllison sossStrategic communicationsService solutionTreasure global incHolding sdn bhdSecurities exchangePartnership supports regional expansion strategyPayment gateway partner forProprietary appGlobal incSdn bhdSouth east asianManage software